1. Home
  2. NVNO vs WLGS Comparison

NVNO vs WLGS Comparison

Compare NVNO & WLGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVNO
  • WLGS
  • Stock Information
  • Founded
  • NVNO 1987
  • WLGS 1981
  • Country
  • NVNO United States
  • WLGS Hong Kong
  • Employees
  • NVNO N/A
  • WLGS N/A
  • Industry
  • NVNO Medical/Dental Instruments
  • WLGS Engineering & Construction
  • Sector
  • NVNO Health Care
  • WLGS Consumer Discretionary
  • Exchange
  • NVNO Nasdaq
  • WLGS Nasdaq
  • Market Cap
  • NVNO 51.7M
  • WLGS 41.7M
  • IPO Year
  • NVNO N/A
  • WLGS 2023
  • Fundamental
  • Price
  • NVNO $2.82
  • WLGS $1.97
  • Analyst Decision
  • NVNO
  • WLGS
  • Analyst Count
  • NVNO 0
  • WLGS 0
  • Target Price
  • NVNO N/A
  • WLGS N/A
  • AVG Volume (30 Days)
  • NVNO 159.6K
  • WLGS 167.4K
  • Earning Date
  • NVNO 10-31-2024
  • WLGS 01-07-2025
  • Dividend Yield
  • NVNO N/A
  • WLGS N/A
  • EPS Growth
  • NVNO N/A
  • WLGS N/A
  • EPS
  • NVNO N/A
  • WLGS N/A
  • Revenue
  • NVNO N/A
  • WLGS $6,825,879.00
  • Revenue This Year
  • NVNO N/A
  • WLGS N/A
  • Revenue Next Year
  • NVNO N/A
  • WLGS N/A
  • P/E Ratio
  • NVNO N/A
  • WLGS N/A
  • Revenue Growth
  • NVNO N/A
  • WLGS 63.69
  • 52 Week Low
  • NVNO $2.45
  • WLGS $0.44
  • 52 Week High
  • NVNO $6.97
  • WLGS $5.57
  • Technical
  • Relative Strength Index (RSI)
  • NVNO 43.42
  • WLGS 38.28
  • Support Level
  • NVNO $2.45
  • WLGS $1.06
  • Resistance Level
  • NVNO $3.00
  • WLGS $2.50
  • Average True Range (ATR)
  • NVNO 0.19
  • WLGS 0.60
  • MACD
  • NVNO 0.00
  • WLGS -0.18
  • Stochastic Oscillator
  • NVNO 50.89
  • WLGS 29.50

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).

About WLGS Wang & Lee Group Inc.

WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED (WLHK). WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage (220v/phase 1 or 380v/phase 3) electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, and water supply and sewage disposal systems.

Share on Social Networks: